SCHEMBL4353285

SCHEMBL4353285

C=C(C)C(=O)Oc1ccccc1CO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.47
ELANE P08246 2/20 0.46
TDP1 Q9NUW8 2/20 0.41
ATM Q13315 2/20 0.41
THRA P10827 1/20 0.40
THRB P10828 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
CYP4F2 P78329 2/20 0.39
CYP4A11 Q02928 2/20 0.39
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
TSHR P16473 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
ESR1 P03372 1/20 0.37
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37
HMGB1 P09429 1/20 0.37
HPGD P15428 1/20 0.37
GGT1 P19440 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL732424 0.87 ELANE (0.47) ELANETDP1ATMTHRATHRB
SCHEMBL147468 0.87 ELANE (0.47) ELANETDP1ATMTHRATHRB
SCHEMBL9998913 0.86 THRA (0.44) EPHX1ELANETDP1ATMTHRA
Mandelic Acid SCHEMBL11302244 0.86 LMNA (0.47) EPHX1ELANETDP1ATML3MBTL1
SCHEMBL27536945 0.84 ELANE (0.45) ELANETDP1ATMTHRATHRB
SCHEMBL27638622 0.84 ELANE (0.45) ELANETDP1ATMTHRATHRB
SCHEMBL3628841 0.83 PTGS2 (0.53) EPHX1ELANETDP1CYP4F2CYP4A11
SCHEMBL31572664 0.83 THRA (0.51) ELANETHRATHRBMTNR1AMTNR1B
SCHEMBL4596507 0.83 THRA (0.51) ELANETHRATHRBMTNR1AMTNR1B
SCHEMBL1232932 0.82 ELANE (0.56) ELANETDP1ATMTSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012098560-A2 PROCESS FOR THE PREPARATION OF MUSCARINIC RECEPTOR ANTAGONIST MSN LABORATORIES LIMITED (IN) 2012-07-26 WO claimed
US-20230161250-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-05-25 US disclosed
US-20090266583-A1 PHOTOSENSITIVE RESIN COMPOSITION, LAMINATE, METHOD OF PRODUCING METAL PLATED MATERIAL, METAL PLATED MATERIAL, METHOD OF PRODUCING METAL PATTERN MATERIAL, METAL PATTERN MATERIAL AND WIRING SUBSTRATE FUJIFILM CORPORATION (JP) 2009-10-29 US disclosed
US-20070082965-A1 Photocuring resin composition, medical device using same and method for manufacturing same JSR CORPORATION (JP) 2007-04-12 US disclosed
EP-0377308-B1 Phenolic resins BORDEN UK LTD (GB) 1993-11-03 EP disclosed
US-5051454-A An esterified phenolic compound, an unesterified phenolic resole and a base and curing BORDEN, INC. (US) 1991-09-24 US disclosed
EP-0377308-A1 Phenolic resins BORDEN (UK) LIMITED (GB) 1990-07-11 EP disclosed
WO-1990006904-A2 PHENOLIC RESINS BORDEN (UK) LIMITED (GB) 1990-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230161250-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN RIMKLA, GAR1, PCCA EPHX1 1243/4885ELANE 1689/4885TDP1 3179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.